Hemispherx Biopharma (HEB)
Hemispherx Biopharma Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -3.11M | -2.74M | -2.30M | -0.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Depreciation, Depletion, Amortization | 0.15M | 0.18M | 0.09M | 0.21M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Non-Cash Items | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Non-Cash Items | 0.15M | 0.18M | 0.09M | 0.21M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | 0.96M | 0.48M | -0.29M | -0.89M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Operating Activities | -1.02M | -0.19M | -0.49M | -0.27M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Cash from Operating Activities | -3.02M | -2.27M | -2.99M | -1.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.95M | -0.47M | -0.35M | -0.03M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Acquisitions, Divestitures | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Investments | 2.68M | 3.59M | 3.08M | 1.34M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Investing Activities | -0.14M | -0.04M | 0.10M | -0.15M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 1.58M | 3.08M | 2.84M | 1.15M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | 1.69M | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.52M | 1.13M | -0.02M | -0.01M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Foreign Exchange Effects | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Change in Cash & Cash Equivalents | -0.92M | 1.94M | -0.17M | -0.67M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash at beginning of period | 2.92M | 3.10M | 4.02M | 2.08M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash at end of period | 3.10M | 4.02M | 2.08M | 2.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
